EUVIMEDEUVIMED entdecken
Crossref

Si@D(AuPt) nanozyme-driven point-of-care testing technology for real-time monitoring of clinical urinary-related indicators

Guangmin Cheng, Wenlong Bai, Xuanming Zhang, Xuan Xia, Tao Zhang, Dong Feng, Lei Wei, Chongwen Wang, Shu Wang, Shuai Zheng

Microchimica Acta · 2025-10 · 192 (10)

DOI: 10.1007/s00604-025-07531-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, online erschienen am 17.09.2025. Verfasst von Guangmin Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Urinary Tract Infections, Point-of-Care Testing, Metal Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science Fund for Distinguished Young Scholars of Guangdong Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To address the challenges of poor system compatibility, low sensitivity, and narrow detection range in traditional colorimetric lateral flow immunochromatographic assay (LFA) for dynamic monitoring of urinary tract infection (UTI) pathogens (biomacromolecules) and antibiotics (small molecules), we propose a colorimetric-enhanced LFA technique based on monodisperse bimetallic composite nanozymes (Si@D(AuPt)), achieving rapid and precise detection of different types of markers in real urinary tract infection samples. The raspberry-like Si@D(AuPt) nanozyme employs a highly stable SiO2 core, with continuous loading of double-layer dense AuPt nanoparticles to provide rough surface area and dense spatial catalytic sites, greatly enhancing the complex sample stability and peroxidase activity of single nanolabel. Furthermore, efficient and stable antibody-nanomaterial coupling was achieved through 5,5'-dithiobis (2-nitrobenzoic acid) (DTNB) molecule mediation, improving the universal detection capability and accuracy of the LFA system. Experimental results show that the platform achieves detection Limits of 11.64 cells/mL for Pseudomonas aeruginosa (sandwich mode), 6.70 pg/mL for gentamicin, and 3.69 pg/mL for cefalexin (competitive mode), with sensitivity at least 400 times higher than traditional colloidal AuNP-based LFA strips. Additionally, the proposed assay demonstrates excellent stability, sensitivity, and specificity in actual urine samples, providing a reliable technical means for real-time monitoring of UTI related indicators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsPoint-of-Care TestingMetal NanoparticlesHumansColorimetryLimit of DetectionGoldPseudomonas aeruginosaAnti-Bacterial AgentsGentamicinsSilicon DioxideChromatography, Affinity

Stichwörter der Autor:innen

Bimetallic composite nanozymesCompetitive modeNanozyme LFAReal-time monitoringSandwich modeUrinary tract infection

Substanzen

GoldAnti-Bacterial AgentsGentamicinsSilicon Dioxide

Autor:innen und Institutionen

  • Department of Nephrology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei, 230036, China.
  • Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510000, Guangdong, China.
  • Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510000, Guangdong, China. wangchongwen1987@126.com.
  • Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei, 230036, China. wangshu@aiofm.ac.cn.
  • Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei, 230036, China. kapposnn@163.com.

Förderung

  • National Natural Science Foundation of China
  • Science Fund for Distinguished Young Scholars of Guangdong Province
  • China Postdoctoral Science Foundation
  • Scientific and Technological Research on Major Issues in Aviation Medicine of Air Force Medical University

Zitieren

APA

Cheng, G., Bai, W., Zhang, X., Xia, X., Zhang, T., Feng, D., Wei, L., Wang, C., Wang, S., & Zheng, S. (2025). Si@D(AuPt) nanozyme-driven point-of-care testing technology for real-time monitoring of clinical urinary-related indicators. Microchimica Acta, 192(10). https://doi.org/10.1007/s00604-025-07531-0

Vancouver

Cheng G, Bai W, Zhang X, Xia X, Zhang T, Feng D, et al. Si@D(AuPt) nanozyme-driven point-of-care testing technology for real-time monitoring of clinical urinary-related indicators. Microchimica Acta. 2025;192(10). doi:10.1007/s00604-025-07531-0

BibTeX
@article{Cheng2025,
  author = {Cheng, Guangmin and Bai, Wenlong and Zhang, Xuanming and Xia, Xuan and Zhang, Tao and Feng, Dong and Wei, Lei and Wang, Chongwen and Wang, Shu and Zheng, Shuai},
  title = {Si@D(AuPt) nanozyme-driven point-of-care testing technology for real-time monitoring of clinical urinary-related indicators},
  journal = {Microchimica Acta},
  year = {2025},
  volume = {192},
  number = {10},
  doi = {10.1007/s00604-025-07531-0}
}
Kostenlos starten →